Table 1 Baseline characteristics of included participants.
From: Accuracy of glomerular filtration rate estimates among patients with cancer
Overall | |
|---|---|
N (%) | 1837 |
Age: years | 68 [61, 74] |
Female: n(%) | 707 (38.5) |
Body mass index: kg/m2 | 25.3 (4.5) |
Body surface area: m2 | 1.9 (0.2) |
Comorbidity count | 1.0 [0.0, 2.0] |
Cancer type (%) | |
Bladder | 599 (32.6) |
Colorectal | 229 (12.5) |
Female genital organs | 129 (7.0) |
Kidney/ureter | 120 (6.5) |
Lung and bronchus | 428 (23.3) |
Male genital organs | 72 (3.9) |
Other | 260 (14.2) |
Metastatic: n(%) | |
Not metastatic | 1212 (66.0) |
Metastatic | 319 (17.4) |
Unknown | 306 (16.7) |
Systemic glucocorticoid use: n(%) | 621 (33.8) |
Diabetes: n(%) | 379 (20.6) |
Hypertension: n(%) | 950 (51.7) |
Cardiovascular disease: n(%) | 576 (31.4) |
Liver disease: n(%) | 232 (12.6) |
mGFR: mL/min | 75 (30) |
eGFRcr CKD-EPI 2009: mL/min | 81 (28) |
eGFRcr EKFC 2021: mL/min | 76 (26) |
eGFRcys CKD-EPI 2012: mL/min | 67 (31) |
eGFRcys EKFC 2023: mL/min | 67 (25) |
eGFRcr-cys CKD-EPI 2012: mL/min | 74 (29) |
eGFRcr-cys EKFC 2023: mL/min | 71 (25) |
